Structure-function relationships in heparin cofactor II: spectral analysis of aromatic residues and absence of a role for sulfhydryl groups in thrombin inhibition.
This study characterizes the structural and functional significance of sulfhydryl residues in human plasma heparin cofactor II (HCII). For quantification of sulfhydryl groups, the extinction coefficient of HCII was redetermined and found to be 0.593 ml mg-1 cm-1 using second-derivative spectroscopy and multicomponent analysis assuming 4, 10, and 2 residues of tryptophan, tyrosine, and tyrosine-O-sulfate per mole of protein, respectively. The results show that tyrosine-O-sulfate residues in HCII and in cholecystokinin peptide fragments (as model compounds) do not significantly contribute to the absorbance spectrum from 280 to 300 nm. A total of three sulfhydryl groups per mole of HCII was detected by Ellman's reagent titration, with or without treatment with dithioerythritol, indicating the absence of intramolecular disulfide bonds. Incubation of HCII with 0.1-10 mM dithioerythritol did not diminish its heparin-enhanced thrombin inhibition activity. Treatment with various sulfhydryl-specific reagents, including p-mercuribenzoate, HgCl2, and N-substituted maleimide derivatives, inactivated HCII. Titration with Ellman's reagent after these reactions identified the modification site as a cysteinyl residue(s). However, complete methanethio derivatization of the sulfhydryl groups of HCII using methyl methanethiosulfonate did not alter heparin-catalyzed thrombin inhibition. These results indicate that the sulfhydryl groups of HCII are not essential for thrombin inhibition. HCII differs from antithrombin III, which contains an essential disulfide bond for heparin-dependent thrombin inhibition (Longas, M. O., et al. (1980) J. Biol. Chem. 255, 3436). Furthermore, within the "serpin" (serine proteinase inhibitor) superfamily, HCII resembles chicken ovalbumin in occurrence of sulfhydryl residues and reactivity with various sulfhydryl group-directed compounds.
Department of Pathology, University of North Carolina, Chapel Hill 27599.
F C
FC
Church
J B
JB
Meade
C W
CW
Pratt
D002730:Chloromercurinitrophenols; D002766:Cholecystokinin / Q000032:analysis; D004220:Disulfides / Q000032:analysis; D004228:Dithionitrobenzoic Acid; D006023:Glycoproteins / Q000494:pharmacology*; D015844:Heparin Cofactor II; D006801:Humans; D008970:Molecular Weight; D010446:Peptide Fragments / Q000032:analysis; D013329:Structure-Activity Relationship; D013438:Sulfhydryl Compounds / Q000032:analysis; D013917:Thrombin / Q000037:antagonists & inhibitors*
D002730:Chloromercurinitrophenols; D004220:Disulfides; D006023:Glycoproteins; D010446:Peptide Fragments; D013438:Sulfhydryl Compounds; C026149:2-chloromercuri-4-nitrophenol; D015844:Heparin Cofactor II; D002766:Cholecystokinin; D004228:Dithionitrobenzoic Acid; D013917:Thrombin